Report Company Directory
- US HG Research: Amgen (AMGN): 3Q24 Earnings — Steady Performance, No Updates On MariTide by Barclays
- US HG Research: Healthcare, Pharma, Health Insurance: What's the Issue? Supply Forecast Looks Limited by Barclays
- US Investment Grade: Top Swaps in Yankees: Banks, Cap Goods, Comms, Cons. Non-cyc, and Utilities by Barclays
- US Investment Grade: Top Swaps in Yankees: Banks, Utilities, Comms, and Energy by Barclays
- Investment Grade: Front end looks BBBetter by Barclays
- US Credit Alpha: Still can't fight the Fed by Barclays
- US Investment Grade: Top Swaps in Yankees: Consumer Non-Cyc and Comms by Barclays
- US HG Research: Pharmaceuticals: 4Q23 Post-Earnings & Issuance Recap — Deleveraging Stories, Execution Risk by Barclays
- US HG Research: Amgen (AMGN): 4Q23 Earnings – All Eyes on Pipeline: GLP-1s and Others by Barclays
- US Credit Alpha: Under the surface by Barclays